This Asthma Drug Can Boost Recovery in COVID-19
Photo: CC0 Public Domain
In a new study from the University of Oxford, researchers found that early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home.
They found clear evidence of an effective COVID-19 treatment for use in primary care that can significantly shorten recovery time.
Inhaled budesonide is a safe, relatively inexpensive, and readily available corticosteroid commonly used around the world in inhalers to treat asthma and chronic obstructive pulmonary disease.